Abstract
Ischemic heart disease (IHD) constitutes the leading global cause of mortality and morbidity. Although significant progress has been achieved in the diagnosis, treatment, and prognosis of IHD, more robust diagnostic biomarkers and therapeutic interventions are still needed to circumvent the increasing incidence of IHD. MicroRNAs (miRNAs) are critical regulators of cardiovascular function and are involved in various facets of cardiovascular biology. While the knowledge of the role of miRNAs in IHD as diagnostic biomarkers has improved, research emphasis on how miRNAs can be effectively used for diagnosis and prognosis of IHD is crucial. This review provides an overview of the biology, therapeutic and diagnostic potential, as well as the caveats of using miRNAs in IHD based on existing research.
| Original language | English |
|---|---|
| Article number | 9001 |
| Journal | International Journal of Molecular Sciences |
| Volume | 23 |
| Issue number | 16 |
| DOIs | |
| State | Published - Aug 2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- cardiac biomarkers
- diagnostics
- ischemic heart disease
- microRNAs
- therapeutic targets
Fingerprint
Dive into the research topics of 'miRNA in Ischemic Heart Disease and Its Potential as Biomarkers: A Comprehensive Review'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver